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Background: Lipoglycans modulate the initiation 
of immune responses by interacting with TLR2. 
Results: A hypermannosylated lipomannan 
variant, once recognized by the immune system, 
enhance both innate responses and Th17 
differentiation. 
Conclusion: Altered lipoglycan structures are 
differently recognised by innate immune cells with 
an impact on the adaptive immune response. 
Significance: Specific lipoglycan structures may 
be useful to modulate immune responses. 
 
SUMMARY (237/250 words) 
Toll-like receptors (TLRs) recognize 
pathogens by interacting with pathogen-
associated molecular patterns such as the 
phosphatidylinositol-based lipoglycans, 
lipomannan (LM) and lipoarabinomannan 
(LAM). Such structures are present in several 
pathogens, including Mycobacterium 
tuberculosis, being important for the initiation 
of immune responses. It is well established that 
the interaction of LM and LAM with TLR2 is a 
process dependent on the structure of the 
ligands. However, the implications of structural 
variations on TLR2 ligands for the 
development of T helper (Th) cell responses or  
in the context of in vivo responses are less 
studied. Herein, we used Corynebacterium 
glutamicum as a source of lipoglycan 
intermediates for host interaction studies. In 
this study, we have deleted a putative 
glycosyltransferase, NCgl2096, from C. 
glutamicum and found that it encodes for a 
novel α(12)arabinofuranosyltransferase, 
AftE. Biochemical analysis of the lipoglycans 
obtained in the presence (wild-type) or absence 
of NCgl2096 showed that AftE is involved in the 
biosynthesis of singular arabinans of LAM. In 
its absence the resulting molecule is a 
hypermannosylated (hLM) form of LAM. Both 
LAM and hLM were recognized by dendritic 
cells, mainly via TLR2, and triggered the 
production of several cytokines. hLM was a 
stronger stimulus for in vitro cytokine 
production and, as a result, a more potent 
inducer of Th17 responses. In vivo data 
confirmed hLM as a stronger inducer of 
cytokine responses and suggested the 
involvement of other pattern recognition 
receptors than TLR2 as sensors for lipoglycans. 
 
The immune system has evolved several 
mechanisms of defense against pathogens, 
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favoring pathogen clearance whilst ensuring host 
integrity. The innate immune system is the first 
line of host defense against invading pathogens, 
being mediated by phagocytes including 
macrophages and dendritic cells
7
 (DCs) (1). These 
cells express host germline-encoded pattern-
recognition receptors (PRRs) that recognize 
specific pathogen-associated molecular patterns 
(PAMPs) present in microorganisms, resulting in 
the initiation of innate immune responses (2). To 
date, the best studied PRRs are toll-like receptors 
(TLRs) that sense components of bacteria, fungi, 
protozoa and viruses, thus playing a major role in 
innate immunity (2).  
 
TLR2 binds a wider range of ligands than 
other members of the TLR family. TLR2 in 
association with TLR1 or TLR6 is essential for 
recognizing bacterial lipoproteins and 
lipopeptides, as well as a variety of compounds 
including lipoteichoic acids, lipoarabinomannan 
(LAM) and zymosan (2). Structural studies have 
revealed that the recognition of lipopeptide ligands 
by TLR2 induces the formation of TLR2-TLR1 or 
TLR2-TLR6 dimers, bringing together the 
intracellular domains of these TLRs, which is 
needed to initiate signaling cascades (3,4). 
However, the structure-function relationship 
between TLR2 and other ligands than lipoproteins, 
particularly LAMs, is not so well understood. This 
issue is relevant in the field of mycobacteria, as 
pathogens of the Mycobacterium genus are well 
known for their unique and complex cell wall, 
composed by several molecules, including 
lipoglycans, able to activate TLR2 (5). 
Lipoglycans are surface exposed macromolecules 
(6) and can be found as lipomannan (LM) and 
lipoarabinomannan (LAM). In mycobacteria, LM 
is a linear 20-25 sugar residue oligopolymer of 
α(1→6) mannose units decorated with 7-10 
singular α(1→2) mannose units. This mature LM 
is proposed to be further glycosylated by a large 
arabinan domain (approximately 70 arabinose 
units), and capped by 2-3 mannose residues 
resulting in mannose-capped LAM (Man-LAM) 
(7,8). The structure of LM and LAM differs 
between virulent and non-virulent species of 
mycobacteria (7-10), suggesting that these 
molecules play a key role in the outcome of host-
pathogen interactions. Importantly, recent 
evidence points to the fact that subtle structural 
variations on LM and LAM determine their 
biological activity and affect immunological 
responses (10-14). It has been suggested that LM 
is a stronger inducer of TLR2 responses than LAM 
(15) and the ability of LM to activate TLR2 is 
determined by the mannan chain length (14). 
Furthermore, truncation of the arabinan domain of 
LAM increases its ability to activate TLR2 (13). In 
addition, truncated LAM leads to altered 
phagocytosis of mycobacteria (16) and, more 
recently, LM from avirulent mycobacteria were 
shown to be less branched and to have shorter 
mannose domains, being more efficiently 
presented to T cells in the context of CD1b (10). 
The acylation state of mycobacterial LM was also 
shown to modulate TLR2 responses (12). 
 
The study of TLR2 in infection and 
immunity has been well addressed (17). In the 
case of Mycobacterium tuberculosis, its in vitro 
recognition by macrophages and DCs strongly 
depends on TLR2, with decreased expression of 
several cytokines in its absence (18-21). In vivo, 
lack of TLR2 did not compromise bacterial control 
(18,19,22-24), but impacted the maintenance of T 
helper (Th) 17 cells in the lung of infected animals 
(25) and granuloma formation (18,19,25). Finally, 
in humans the association of tlr2 polymorphisms 
with susceptibility to tuberculosis remains 
controversial (26) and appears to greatly depend 
on the genetics of the host-/bacteria interplay (27). 
 
In this study, we sought to further 
understand the impact of the arabinan branching in 
the phenotype of Th cell responses generated in 
vitro. Because most of the genetic loci encoding 
for cell wall biogenesis are essential in the context 
of M. tuberculosis, we have used Corynebacterium 
glutamicum as a model to obtain LAM variants 
(8,28,29). We have generated a C. glutamicum 
mutant deficient in a putative glycosyltransferase 
(NCgl2096) which resulted in abrogation of LAM 
and led to the accumulation of a novel form of 
hypermannosylated lipomannan (hLM). Both 
LAM and hLM were recognized by DCs, mainly 
via TLR2, and triggered the production of both 
pro- and anti-inflammatory cytokines. hLM was a 
stronger stimulus for in vitro cytokine production 
and also a more potent inducer of Th17 responses. 
In vivo responses were also increased upon hLM 
recognition. Importantly, our in vivo data point to 
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the involvement of other PRRs than TLR2 as 
sensors for lipoglycans. 
 
EXPERIMENTAL PROCEDURES 
  
Bacterial strains and growth conditions 
C. glutamicum and Escherichia coli 
DH5mcr were grown in BHI, CGXII and LB at 
30°C and 37°C with kanamycin and ampicillin 
(50µg/ml), wherever appropriate. All chemicals 
were of reagent grade and obtained from Sigma-
Aldrich.  
 
Construction of plasmids, mutant and 
complemented strain 
To delete aftE, the deletion vector 
pK19mobsacB∆-aftE was made and cross-over 
PCR was used with genomic DNA of C. 
glutamicum as template and two different PCRs 
with primer pairs AB and CD (Supplementary 
Table 1). The resulting PCR product served as 
template for primer pairs AD. The PCR product 
contained 18 nucleotides of the 3´-end of the 
respective gene together with genomic upstream 
sequences, and 36 nucleotides of the 5´-end 
together with genomic downstream sequences. All 
plasmids used in this work were confirmed by 
sequencing. AftE was deleted by electroporating 
pK19mobsacB∆-aftE into C. glutamicum and then 
selecting for sucrose resistance (30). 
Chromosomal deletions were confirmed using 
primer pairs AD, as well as the additional new 
primer pairs EF (overhangs required for 
hybridisation are given in italics in Supplementary 
Table 1) hybridising outside of the regions used 
for plasmid constructions. To construct pEKEx2-
Cg-aftE, Cg-aftE was amplified using primer pairs 
AD, with the former providing the sequence 
CTGCAG as a ribosome binding site. The 
amplified product was ligated between PstI and 
EcoRI in pEKEx2. Plasmid pEKEx2-Cg-aftE was 
electroporated in C. glutamicum∆aftE resulting 
into C. glutamicum∆aftE pEKEx2-Cg-aftE. 
 
Extraction and biochemical characterisation of 
lipoglycans 
Lipoglycans were extracted from 
delipidated cells as previously described (31,32) 
and treated with H2O2 before immunological 
assays to remove any endotoxin contamination 
(13) and to yield a negative Limulus Amebocyte 
Lysate test using E-TOXATE
TM 
(Sigma-Alderich). 
For MALDI-TOF-MS, 2,5-dihydroxybenzoic acid 
was used as a matrix and samples (0.5µl; 10µg/µl) 
were analysed on Voyager DE-STR MALDI-TOF 
instrument (PerSeptive Biosystems, MA) using 
linear mode detection. Furthermore, lipoglycans 
were derivatised for glycosyl and linkage analysis 
as previously described (31). All the data were 
collected and analysed using Xcaliber (v.1.2). 
 
HEK293 cell culture and stimulation assay  
Human HEK293 cells transfected with 
TLR2 (33) were cultured as described previously 
(13). For stimulation assays, trypsine-released 
HEK293 cells were washed with and resuspended 
in culture medium at 5.55x10
5
 cells/ml after 
which 90µl cell suspension (=5x10
4
 cells) was 
transferred to a 96-well U-bottom plate (Greiner) 
and left for 2h to let the cells re-adhere. After this, 
cells were stimulated (in triplicate) with 50µg/ml 
LAM or hLM in a final stimulation volume of 
100µl. Non-stimulated cells or cells stimulated 
with 50ng/ml Pam3CSK4 served as a negative and 
positive controls, respectively. Culture 
supernatants were harvested after 24h by 
centrifugation and analysed for IL-8 content using 
ELISA (Invitrogen).  
 
Animals  
Eight-week-old female C57BL/6 (BL/6) 
and BalbC mice were obtained from Charles River 
(Barcelona, Spain); TLR2
-/- 
mice in a C57BL/6 
background and DO11.10 mice in a BalbC 
background were maintained at ICVS. All 
protocols were performed according to the 
European Union Directive 86/609/EEC and 
previously approved by the Portuguese authority 
DGV. 
 
Culture of Bone Marrow Derived DCs. 
5x10
6
 bone marrow cells were seeded per 
well in 6-well plates in DMEM supplemented with 
10% FBS, 1% HEPES, 1% sodium piruvate 
(Gibco) and 20% of GM-CSF and incubated at 
37ºC in 5% CO2. On days 2 and 4, the medium 
was renewed. On day 6, non-adherent cells were 
collected, resuspended in fresh medium with 20% 
GM-CSF, and 2.5x10
6
 cells per well cultured 
overnight. On day 7, cultures were stimulated with 
different doses of LAM or hLM (0-100μg/mL), 
with LPS (25ng/mL) or left unstimulated as 
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controls and RNA and supernatants harvested 6 
and 24h thereafter, respectively. EC50 was 
calculated using a non linear fit regression in 
the dose-response curves. 
  
Co-cultures of CD4
+
 T cells and DC.  
Naive CD4
+
 T cells were purified from 
spleens of OVA323-339-TCR transgenic DO.11.10 
mice using magnetic CD4
+
 beads (GK1.5; 
Miltenyi Biotec). These cells (1x10
6
 cells/ml) were 
co-cultured with BalbC DCs (5x10
5
 cells/ml) in 
the presence of LAM or hLM (10μg/mL) and 
peptide OVA323–339 (2.5μM) for 7 days at 37°C in 
5% CO2. CD4
+
 T cells (1x10
6
 cells/ml) were 
recovered on day 7 and co-cultured with DCs for 
an additional round of differentiation with fresh 
BalbC DCs (5x10
5
 cells/ml) and LAM or hLM for 
an additional 3 days at 37°C in 5% CO2. At the 
end of the culture, CD4
+
 T cells were recovered 
and re-stimulated in the presence of PMA 
(50ng/mL) and Ionomycin (500ng/mL) for 4 hours 
and of Brefeldin A (40μg/mL) for the last 2 hours. 
The frequency of OVA323–339-specific, IFN-γ- or 
IL-17-producing CD4
+
 T cells was determined by 
flow cytometry. 
 
In vivo model of peritoneal challenge.  
Groups of 5 mice were injected intra-
peritoneally with 50 or 400μg/mouse of LAM or 
hLM and sacrificed at specific time points post-
challenge. Peritoneal cells were harvested with 
cold PBS, counted and processed for flow 
cytometry or RNA extraction and real-time PCR 
analysis. Resident PECs were harvested from 
unstimulated BL/6 or TLR2
-/-
 mice and stimulated 
in vitro for 3 or 6h with LAM and hLM (10μg/ml). 
Cytokine mRNA quantification was performed by 
real-time PCR. 
 
Real time-PCR analysis.  
Total RNA was extracted with TRIzol® 
(Invitrogen) and reverse transcription was 
performed using ReverteAidTM H Minus First 
Strand cDNA Synthesis Kit (Fermentas). The 
cDNA was then subjected to real-time PCR for 
quantification of IL-12p40, IL-12p35, IL23p19, 
TNF-α, IL-6, IL-10, CXCL2 and Ubiquitin 
(Supplementary Table 1) with SYBR Green 
Supermix (Bio-Rad) in an CFX 96 Real-Time 
(BioRad) system. The quantification of the target 
genes was analysed using the CFX 96 Real-Time 
software and normalised against mouse ubiquitin 
mRNA.  
 
Flow cytometry analysis.  
Cell surface markers were analysed using 
specific antibodies against Ly6G (APC, 1A8; 
BioLegend), GR1 (PercP-Cy5.5, RB6-8C5; 
BioLegend) and CD11b (PE, M1/70; eBioscience) 
for identification of neutrophils, or against CD4 
(eFluor450, RM4-5; eBioscience) for 
identification of CD4
+
 T cells. For intracellular 
detection of cytokines, specific antibodies for IL-
17 (PE, eBio17B7; eBioscience) and IFN- (FITC, 
XMG1.2; eBioscience) or Isotype control 
antibodies (BioLegend) were used. Fluorescence 
was analysed using an LSRII flow cytometer and 
FACSDiva Software (BD Bioscience) and data 
with FlowJo software (TreeStar).  
 
ELISA.  
Supernatants from LAM- or hLM-
stimulated DCs were screened for IL-12p40, IL-
23, TNF-α, IL-6, IL-12p70 and IL-10 by Ready 
Set-Go ELISA kits (eBioscience). 
 
Statistical analysis.  
One-way ANOVA post-hoc Tukey’s t test was 
used with a confidence interval of 95% when 
multiple comparisons were evaluated. Two-
way ANOVA was used in kinetic evaluations. 
Data were expressed as means ± SEM; p<0.05 
was considered statistically significant. 
 
RESULTS 
 
Construction and growth of C. 
glutamicum∆aftE  
In Corynebacterineae, like M. tuberculosis 
and C. glutamicum, α(1→6) mannosyltransferases 
MptA (Rv2174/NCgl2093) and MptB 
(Rv1459c/NCgl1505) catalyse the α(1→6)-Manp 
transfer to distal and proximal parts of the LM 
backbone (32,34) and MptC (Rv2181/NCgl2100) 
adds singular α(1→2)-Manp on linear LM (35,36). 
In C. glutamicum, two other glycosyltransferases 
are present in tandem with MptC, whilst the role 
of MptD (NCgl2097) has been established as a 
second α(1→2) mannopyranosyltransferase 
involved in mannan branching of LM and LAM 
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(35), the role of the third glycosyltransferase, 
NCgl2096, remains to be identified. The 
NCgl2096 encoded protein (named as AftE 
hereafter) consists of eight transmembrane helices 
(TMH) and two negatively charged loops (6 Asp, 
2 Glu) (37), probably required for 
glycosyltransferase activity as observed for the 
arabinosyltransferase Emb (38). Furthermore, 
BLAST analysis suggests close similarity to 
mycobacterial mannopyranosyltransferases MptC 
and PimE and arabinosyltransferases EmbA, 
EmbB and EmbC, suggesting it to be a 
glycosyltransferase.  
 
To further understand the function of 
AftE, a non-replicative plasmid 
pK19mobsacB∆aftE was constructed consisting of 
13 nucleotides of the 3´-end of aftE together with 
genomic upstream sequences, and 36 nucleotides 
of the 5´-end together with genomic downstream 
sequences. This vector was used to transform C. 
glutamicum to kanamycin resistance (Kan
r
) 
indicating chromosomal integration. Subsequently, 
sucrose resistance (Suc
r
) clones were selected in a 
second round of positive selection, indicating loss 
of the vector-bound sacB function (30). From 12 
Kan
s
 and Suc
r
 clones analysed via PCR, 7 had lost 
aftE, whereas in the remaining 5 the wild type 
phenotype was restored. One of the 
representatives’ clones with deleted aftE was 
selected and referred to as C. glutamicum∆aftE. In 
addition, aftE was cloned in a shuttle vector 
pEKEx2 and electroporated into C. 
glutamicum∆aftE to achieve the complemented 
strain, C. glutamicum∆aftE pEKEx2-Cg-aftE. C. 
glutamicum∆aftE was grown in liquid CGXII and 
BHI media and its growth pattern was studied. C. 
glutamicum∆aftE had a slightly reduced growth 
rate of 0.32±0.01 h
-1
 in comparison to 0.39±0.02 h
-
1 
of wild type C. glutamicum on CGXII (data not 
shown). A similar trend was seen on BHI medium 
suggesting that AftE is not vital for C. 
glutamicum, but nevertheless required to ensure 
optimal growth. Such trends have been observed 
previously for other glycosyltransferases involved 
in cell wall synthesis like Emb, MptA and AftA 
(32,39,40). 
 
Purification and general features of lipoglycans 
Lipoglycans from C. glutamicum, C. 
glutamicum∆aftE and C. glutamicum∆aftE 
pEKEx2-Cg-aftE were extracted from delipidated 
cells as described previously (31,35). The crude 
lipoglycan extract was subjected to hydrophobic 
interaction chromatography followed by gel 
permeation chromatography for separation of LM 
and LAM, which were examined on 15 % SDS-
PAGE. Crude extracts from C. glutamicum 
showed the presence of LM (a mixture of 
phosphate-myo-inositol anchored Cg-LM-A and 
glucouronic acid anchored Cg-LM-B with 
identical mannan backbone (34,41)) and LAM, 
whilst lipoglycans from C. glutamicum∆aftE 
showed subtle differences in their migration on 
SDS-PAGE (Figure 1a). Lipoglycan fraction from 
C. glutamicum∆aftE consisted of two species, one 
with higher molecular weight lipoglycan migrating 
faster than LAM from wild type, and another 
lower molecular weight lipoglycan migrating 
similar to LM from wild type (Figure 1a). 
Furthermore, matrix-assisted laser 
desorption/ionisation-time of flight-mass 
spectrometry (MALDI-TOF-MS) of the 
lipoglycans showed that LAM from wild type C. 
glutamicum exhibited a broad unresolved peak 
centered at m/z 15000, indicating a molecular 
weight of approximately 15 kDa with major 
molecular species consisting of 87 sugar units 
(based on molecular weight of Ac1PIM2 with three 
sugar units, m/z 1398). The MALDI-TOF-MS of 
higher molecular weight lipoglycan from C. 
glutamicum∆aftE showed an unresolved peak 
which centered around m/z 13000, suggesting the 
loss of approximately 13 sugar units (Figure 1b). 
However, there were no major differences 
between LM from C. glutamicum and smaller 
molecular weight lipoglycan from C. 
glutamicum∆aftE (data not shown). The presence 
of a smaller molecular weight lipoglycan which is 
similar to LM, and a higher molecular weight 
lipoglycan which is shorter than the wild type 
LAM in C. glutamicum∆aftE, suggested that AftE 
is involved in the biosynthesis of LAM and not 
LM. Complementation of C. glutamicum∆aftE by 
transformation with plasmid pEKEx2-Cg-aftE 
restored the wild type phenotype (Figure 1a). 
 
Molecular composition and linkage analysis of 
lipoglycans  
Purified lipoglycans were processed and 
converted into alditol acetates and their glycosyl 
composition was determined by gas 
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chromatography (GC). Based on 1 inositol per 
molecule of LAM, the molecular composition of 
LAM from wild type C. glutamicum was 
determined. It yielded a ratio of 1 inositol, 20 
arabinose and 65 mannose residues, which is in 
accordance to our previous studies (Figure 2a) 
(31,35). In addition, LM from wild type C. 
glutamicum consists of 28 sugars with a molecular 
ratio of 1 inositol (for Cg-LM-A) or 1 glucouronic 
acid (for Cg-LM-B) over 27 mannose units 
(32,41). This observation, which was overlooked 
in previous studies, suggests that in comparison to 
LM,  LAM has a larger mannan domain made up 
of approximately 65 mannose residues, which 
might be due to extended activities of MptA, 
MptC and MptD (35). Surprisingly, higher 
molecular weight lipoglycan from C. 
glutamicum∆aftE showed complete absence of the 
arabinan peak and a ratio of 1 inositol to 74 
mannoses, a reduction of 13 sugar units in 
comparison to LAM from wild type C. 
glutamicum (Figure 2a). Complete absence of the 
arabinan peak should have resulted in the loss of 
20 arabinose units, instead of 13 units, suggesting 
that the loss of arabinan units was compensated by 
some additional mannosylation of LAM 
intermediate, probably by MptC and MptD. This 
may be due to a greater availability of branching 
sites generated due to deletion of aftE. Due to the 
absence of arabinose and hyper-mannosylation, 
this molecule will be hereafter referred to as 
hypermannosylated-lipomannan (hLM).  
 
The glycosyl linkages present in each 
species of lipoglycans were analysed by gas 
chromatography-mass spectrometry (GC-MS) by 
per-O-methylated alditol acetate derivatives 
prepared from purified lipoglycans. LAM from 
wild type C. glutamicum indicated a normal 
profile of glycosidic linkages corresponding to t-
Ara (34%), t-Man (15%), 6-Man (10%), 2-Man 
(17%), and 2,6-Man (24%). However, mutant 
hLM from C. glutamicum∆aftE was found to be 
completely devoid of t-Ara branching residues and 
possessed a significant increase in the amount of t-
Man (39%), 6-Man (5%), 2-Man (18%), and 2,6-
Man (38%) (Figure 2b). Linkage analysis of LM 
from C. glutamicum∆aftE suggested a slightly 
increased branching degree, approximately 87% in 
comparison to 75% of LM from wild type C. 
glutamicum (data not shown). 
 
In conclusion, by deleting AftE we 
obtained a hypermannosylated intermediate of 
lipoglycans, devoid of singular arabinan 
(Supplementary Figure 1). Next we investigated 
whether the biological activity of this structure is 
different to that of LAM from wild type C. 
glutamicum, particularly in what concerns the 
modulation of immune responses via TLR2. We 
focused our study on wild type - LAM vs. hLM, as 
these two molecules differ in arabinan branching 
and degree of mannosylation. Furthermore, the 
LM from wild type C. glutamicum is dominated 
by mono-acylated glucouronic acid anchored LM 
(>90%) and has a poor TLR2 activity and 
therefore has not been included in this study (data 
not shown). 
 
Arabinose branching of LM impacts T helper 
cell differentiation 
Several factors determine the polarization 
of Th cell differentiation, including the 
engagement of specific TLRs (42). The impact of 
structural variations of LAMs in CD4+ Th cell 
differentiation has not been addressed before. 
Taking advantage of the purified wild type-LAM 
and hLM from C. glutamicum and C. 
glutamicum∆aftE, respectively, we addressed this 
issue. For this, primary mouse bone marrow-
derived DC were co-cultured with purified CD4+ 
T cells, from OVA TCR transgenic DO11.10 mice 
(Balb/c background), in the presence of LAM or 
hLM and of OVA peptide (OVA323-339, the antigen 
recognized by the transgenic TCR in DO11.10 
CD4+ T cells). The intracellular cytokine profile 
of the differentiated CD4+ T cells obtained at the 
end of the co-culture was evaluated by flow 
cytometry. Because both Th1 and Th17 have been 
described in infections with mycobacteria, we 
focused our analysis in IFN-γ- and IL-17-
producing T cells. Both LAM and hLM stimulated 
CD4+ T cell differentiation into IL-17-producing 
cells, although in the presence of hLM the 
percentage of IL-17-producing CD4+ T cells 
reached significantly higher values (Figure 3a). 
Also, hLM but not LAM, increased the percentage 
of CD4+ T cells differentiating into Th1 cells 
producing IFN-γ, although this was a modest 
effect (Figure 3a). The differences observed were 
most likely not due to different proliferation rates 
of Th cells, as the number of cells recovered at the 
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end of culture was similar to all conditions 
(Supplementary Figure 4). 
  
The differentiation of Th cells is 
controlled in part by the cytokine environment 
generated by the antigen presenting cell. Indeed, 
the presence of IL-12 (composed of p40 and p35 
monomers) is essential for the development of Th1 
responses (43), whereas IL-6 together with TGF-β 
in the microenvironment promotes Th17 
differentiation (44). Th17 cells also require as a 
survival factor IL-23, an heterodimer of p40 and 
p19 (44). Following our previous findings (Figure 
3a), we sought to understand whether the 
differential impact of LAM and hLM in Th1 and 
Th17 cell differentiation was due to the cytokine 
profile induced by these molecules in DC. To test 
our hypothesis, we stimulated mouse bone 
marrow-derived DC (of Balb/c origin) with LAM 
or hLM and measured the production of IL-12, IL-
23 and IL-6 24h post-stimulation. As shown in 
Figure 3b, hLM is a stronger inducer of each of 
these cytokines, which is in line with its effect on 
Th cell differentiation. Of note, the same pattern 
was observed for the induction of TNF and IL-10 
(Figure 3b). As expected, unstimulated DC 
produced only negligible to non detected cytokine 
amounts (Figure 3b). Our findings are in 
agreement with previously published results, 
reinforcing the idea that branching of LM and 
addition of arabinose residues contribute to a more 
controlled cellular response in terms of cytokine 
production (13-15). However, we now additionally 
implicate variations on lipoglycan structures on 
the outcome of Th immune responses. 
 
Activation of DC by LAM and hLM is TLR2-
mediated 
Next we investigated if TLR2 activation 
was implicated on the differential response of DC 
to LAM and hLM depended on TLR2 activation. 
For that, we started by measuring the response of 
human HEK cells transfected with TLR2 to LAM 
and hLM. We observed that hLM, as compared to 
LAM, induced a significantly increased activation 
of TLR2 as demonstrated by the enhanced TLR2-
dependent IL-8 production by the HEK cells 
(Figure 4a). Of note, hLM was also more potent in 
inducing IL-8 than the TLR2 agonist Pam3CSK4 
(Figure 4a). We then stimulated bone marrow-
derived DC, generated from WT (BL6) or TLR2 
deficient mice, with LAM or hLM and at different 
time points measured the transcription and 
production of IL-12p40, p35, p19 and IL-6, as 
well as of TNF and IL-10. Both transcription and 
secretion of all cytokines tested were higher upon 
hLM stimulation of DC than upon LAM 
stimulation (Figure 4b and c). As expected, DC 
responded to LPS stimulation with the production 
of several cytokines (Figure 4c). Furthermore, 
TLR2 mediated the recognition of both LAM and 
hLM, since cytokine expression and secretion by 
stimulated DC was clearly decreased in its absence 
(Figure 4b and c). Of note, other PRRs than TLR2 
must also be involved in the recognition of LAM 
and hLM, as in the absence of TLR2 cytokine 
expression was not fully abrogated (Figure 4b and 
c). Interestingly, the increased potency of hLM to 
activate DC was not only reflected on the 
expression of pro-inflammatory cytokines, but also 
on the expression and production of the anti-
inflammatory molecule IL-10 (Figure 4b and c). 
For both IL-6 and TNF, we also determined the 
response of WT DC to increasing doses of LAM 
or hLM. For each dose tested, the stimulatory 
activity of hLM was higher than that of LAM 
(Supplementary Figure 5). Moreover, a clear 
difference in the EC50 of the two molecules was 
observed (285.1±2.0µg/ml vs 10.7±1.2µg/ml in 
the case of TNF and 114.3±1.4µg/ml vs 
15.6±1.1µg/ml in the case of IL-6, for LAM vs 
hLM respectively). 
 
These findings suggest that changes on 
LAMs are discriminated by TLR2, being the 
stronger induction of TLR2 via hLM broad, with 
an impact in the various signaling pathways 
triggered by this receptor and not only on those 
leading to pro-inflammatory cytokines. 
 
hLM is a stronger inducer of in vivo immune 
responses 
Considering our in vitro data showing that 
hLM is a stronger inducer of DC responses, with 
an impact on Th cell differentiation, we next 
investigated the effect of LAM versus hLM during 
in vivo immune responses. For this, we injected 
mice (WT vs TLR2
-/-
) intra-peritoneally with 
purified LAM or hLM and measured, at different 
times post-injection, cytokine production at the 
site of stimulation. Total peritoneal cells were 
harvested, their RNA extracted and the relative 
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mRNA expression of several cytokines quantified 
by real time PCR. In contrast to what was 
observed in vitro upon DC stimulation with LAM 
or hLM, in vivo the majority of the molecules 
tested were induced in a TLR2-independent way. 
In fact, absence of TLR2 did not compromise 
TNF, IL-6 or CXCL2 (the mouse homologue of 
human IL-8) expression induced by LAM or hLM 
(Figure 5a). Lack of TLR2 did however contribute 
to a significant decrease on IL-10 induced in vivo 
by LAM or hLM (Figure 5a). Of note, as 
compared to LAM, hLM induced a higher 
expression of the tested pro-inflammatory 
cytokines and also of the anti-inflammatory 
cytokine IL-10 and the chemokine CXCL2 
(Supplementary Figure 6a). To investigate if the 
profile of TLR2-independent in vivo responses 
observed for LAM vs hLM was mainly due to the 
recruitment of new cells or was a feature of the 
resident PECs, we collected peritoneal cells from 
non-stimulated mice, activated them in vitro for 3 
or 6h with LAM or hLM and analysed the 
expression of cytokines in response to this acute 
stimulation. We found that hLM induced stronger 
responses than LAM by resident PECs and that, 
with exception of IL-10, these responses were 
TLR2-independent (Supplementary Figure 7). 
 
Considering that we had detected high IL-
8 production by HEK cells stimulated with hLM 
(Figure 4a) and also high CXCL2 in our in vivo 
model upon hLM administration (Supplementary 
Figure 6a), and since IL-8 is a molecule involved 
in neutrophil recruitment, we investigated changes 
in the numbers of neutrophils recruited upon LAM 
or hLM injection. Although both LAM and hLM 
induced an increase on the total number of 
recruited neutrophils throughout time, this increase 
was significantly more pronounced (approximately 
50% more) in the case of hLM (Supplementary 
Figure 6b). Furthermore, this increase in 
neutrophil recruitment was independent of TLR2 
(Figure 5b). Of note, increasing the dose of 
administered LAM or hLM did not affect the 
differences observed, i.e., hLM was still a higher 
inducer of neutrophil recruitment than LAM 
(Supplementary Figure 6c). The intra-peritoneal 
injections of either LAM or hLM in BL/6 mice did 
not influence the total number of cells collected 
from the peritoneum at any of the time points 
tested (Supplementary Figure 6d), suggesting that 
another cellular population is decreased as the 
influx of neutrophils happened.  
 
Collectively, our data suggest that hLM is 
a stronger inducer of in vivo and in vitro immune 
responses than LAM. Although in DC cultures the 
effect of both LAM and hLM is mainly mediated 
by TLR2, additional PRRs to TLR2 must 
differentially recognize these structures in an in 
vivo setting. 
 
DISCUSSION 
 
TLRs are among the best studied PRRs, 
with a recognized role in protecting the host 
against infection, but also in contributing e to 
acute and chronic inflammation, as well as to 
cancer, if inappropriately activated (45). The need 
for an appropriate regulation of TLR responses 
calls for a deep understanding of the structural 
interaction of TLRs with their ligands. We are 
particularly interested in understanding the 
structure-function relationship between TLR2 and 
lipoglycans, such as LM and LAM. A growing 
body of evidence strongly suggests that the 
structure of LM and LAM affects their interaction 
with TLR2, thus modulating the outcome of the 
innate immune response (11-15). Understanding 
the details of these interactions is essential in the 
context of various infections, including those by 
M. tuberculosis that represent the second most 
common infectious cause of mortality and 
morbidity (46). Importantly, although still 
controversial, a role for TLR2 has been described 
during primary and secondary M. tuberculosis 
infection (18,19,22,23,25,47), and polymorphisms 
in the tlr2 gene have been associated with 
susceptibility to tuberculosis (48).  
 
Although the structural interactions of 
TLR2 with lipoprotein ligands have been 
addressed before by X-ray crystallography (3,4), 
those mediating the interaction of TLR2 with 
lipoglycans are less studied. The detailed study of 
structural-functional interactions of lipoglycans 
and TLR2 requires the availability of different 
structural variants and mimics of lipoglycans. In 
M. tuberculosis most of the genetic loci encoding 
for cell wall biogenesis are essential, which limits 
the availability of these molecules with variable 
structures. For this reason, we have in the past 
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successfully used C. glutamicum as a ‘proof of 
principle’ to understand the biosynthesis of LM 
and LAM in mycobacteria (8,32,34,35,49). The 
biosynthetic pathway of LAM is complex, 
involving a series of enzymes that coordinately 
add complexity to the growing lipoglycan (8). 
Herein, we identified a novel putative 
glycosyltransferase, AftE, from C. glutamicum, 
which adds singular arabinose branches on LAM 
intermediate, resulting into a complete structure of 
LAM. Biochemical analysis of higher molecular 
weight lipoglycan from C. glutamicum∆aftE 
produced a shorter mutant lipoglycan, hLM, in 
comparison to LAM from wild type. The glycosyl 
composition and linkage analysis of hLM 
suggested complete absence of arabinan or t-Ara. 
Further biochemical analysis suggested that hLM 
is a novel lipoglycan with an extended mannose 
backbone with higher α(1→2)-Man units probably 
due to the hyper-action of MptC and MptD on 
branching sites created due to the absence of t-Ara 
residues in C. glutamicum∆aftE. Cumulatively, 
our study sheds light on the synthesis of an 
additional lipomannan-like lipoglycan, hLM, 
which may be either an aberrant LM accumulating 
as a result of lack of arabinosylation or a precursor 
of LAM before arabinosylation. Presumably, 
mature LM with MPI anchor undergoes further 
mannosylation in α(16) direction to yield 
branching sites for α(12)-Man and α(12)-Ara. 
There is high probability that one or both of 
α(16)mannopyranosyltransferases, MptA and 
MptB add further α(16)-Man units to the mature 
LM (32,34), providing further branching sites for 
arabinose and mannose units for LAM (35).  
 
We therefore generated two different 
structural variants of LAM, useful for studying the 
structural-functional relationship between this 
class of PAMPs and TLR2. Our findings show 
that, independently of the dose tested, hLM 
significantly induced higher cytokine secretion by 
DC cultures than LAM. Moreover, hLM was also 
more efficient than LAM in activating DC, as 
reflected by its lower values of EC50. 
Furthermore, hLM was also a more potent 
inducer of in vivo responses than LAM, in a model 
of intra-peritoneal injection. Our findings clearly 
implicate TLR2 as the main PRR involved in in 
vitro DC recognition of both LAM and hLM, thus 
suggesting that the structure of lipoglycans, in 
particular the extent of arabinan branching, 
influences their interaction with TLR2 and 
modulates DC responses. These findings are in 
agreement with previously published studies (13-
15). We also provide evidence that as a result of 
differential DC activation by LAM and hLM, a 
Th17-biased T cell response was generated in 
response to a microenvironment rich in hLM. It 
will be important in future to investigate the 
mechanistic basis for the stronger hLM-induced 
TLR2-mediated response observed in DC. It is 
possible that hLM interacts with TLR2 with a 
higher affinity that LAM or that it induces the 
recruitment of more intracellular signaling 
adaptors. It will be interesting to pursue these 
studies to further understand how TLR2 ligands 
other than lipoproteins interact with TLR2 and 
initiate TLR2-mediated immune responses. 
Interestingly, our data suggest that DC may 
respond to LAM in a stronger way than HEK cells 
transfected with TLR2. This finding may provide 
some hints on the way lipoglycans interact with 
TLR2. It is tempting to speculate that LAM may 
preferentially interact with TLR2:TLR1 or 
TLR2:TLR6 heterodimers (absent in HEK cells 
expressing TLR2, but existent in DC), whereas 
hLM may have the ability to trigger cellular 
responses via TLR2 homodimers. 
 
Our findings show that, similarly to what 
was observed in vitro, in vivo, lack of arabinose 
branching correlates with enhanced immune 
responses. However, in contrast to what was 
observed for DC cultures, in vivo, other PRRs in 
addition to TLR2 are certainly involved in the 
differential recognition of lipoglycans. It is 
possible that in our in vivo model other cells than 
DCs are the major sensors for LAM and hLM, 
thus explaining the difference observed in DC 
cultures and in the peritoneal cavity. This issue 
remains to be investigated, being cells expressing 
DC-SIGN and mannose receptors good candidates 
for the recognition of LAM and hLM (50,51). 
Further studies will be of interest and important to 
clarify both these issues: which cells and which 
PRRs recognize and differentiate lipoglycan 
structural variants. Of note, acute stimulation of 
resident PECs with LAM or hLM induced 
cytokine expression independently of TLR2, 
suggesting that at least peritoneal macrophages 
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differ from DCs in their way of recognizing and 
responding to lipoglycans. Neutrophils are also 
good candidate cells, as we observed an influx of 
neutrophils to the peritoneum cavity upon LAM or 
hLM administration. Our data opens avenues for 
the modulation of innate and acquired immune 
responses by taking advantage of different LAM 
structures. This is particularly important in the 
context of infections by M. tuberculosis, where an 
appropriate balance of Th1 versus Th17 cell 
responses is critical for bacterial control both in 
primary infection and vaccination and for 
pathology prevention (52,53). It is possible that, 
by modulating TLR2 signals, a faster and more 
potent Th17 response is achieved, which has been 
shown to be fundamental for efficient vaccination 
(53).  
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FIGURE LEGENDS 
 
FIGURE 1: Lipoglycan profiles of C. glutamicum, C. glutamicumΔaftE and C. glutamicumΔaftE 
pEKEx2-aftE. (a) Lipoglycans were extracted as described in methods and analysed using SDS-PAGE 
and visualised by Pro-Q emerald glycoprotein stain (Invitrogen). Lipoglycan profiles are represented with 
standard molecular weight markers of glycoproteins of 180, 82, 42 and 18 kDa. (b). MALDI-TOF-MS 
spectra of LAM from C. glutamicum and hLM from C. glutamicumΔaftE. For this, 2,5-dihydrobenzoic 
acid was used as a matrix and the spectra were acquired in the linear negative mode with delayed 
extraction. Lipoglycans were extracted from delipidated cells as previously described (31,32) and treated 
with H2O2 before immunological assays to remove any endotoxin contamination (13) and to yield a 
negative Limulus Amebocyte Lysate test using E-TOXATE
TM 
(Sigma-Alderich). 
 
FIGURE 2: Glycosyl composition and linkage analysis of lipoglycans from C. glutamicum and C. 
glutamicumΔaftE. (a). For glycosyl compositional analysis, purified lipoglycans were hydrolysed, 
reduced and per-O-acetylated as described in methods. Resulting alditol acetates were subjected for GC 
analysis. Ara, arabinose; Man, mannose. (b). For determining the sugar linkages present in these 
lipoglycans species, lipoglycans were per-O-methylated, hydrolysed, reduced and per-O-acetylated. The 
resulting partially per-O-methylated, per-O-acetylated alditol acetates were analysed using GC-MS. The 
partially per-O-methylated, per-O-acetylated alditol acetates were identified based on their characteristic 
alditol cleavage acetal profiles: t-Ara (m/z 118, 161), t-Man (m/z 118, 102, 145, 161, 162, 205), 2-Man 
(m/z 129, 130, 161, 190), 6-Man (m/z 118, 129, 162, 189, 233) and 2,6-Man (m/z 129, 130, 189, 190). 
 
FIGURE 3: hLM is a stronger inducer of Th17 cells than LAM. Naïve CD4+ T cells from DO11.10 
mice were co-cultured with BalbC DCs in the presence of 2.5μM of peptide OVA323-339 and/or 10μg of C. 
glutamicum LAM or hLM for 10 days. (a) Graphs and Dot plots of FACS data of IL-17 and IFN-γ 
production by differentiated CD4
+
 T cells restimulated with PMA and Ionomycin in the presence of 
brefeldinA. Each dot plot and column represents the mean of three wells. (b) Cytokine production by DCs 
generated from BalbC mice and stimulated for 24 hours with LAM or hLM (10µg/mL) or left 
unstimulated (Medium) was evaluated by ELISA. In all cases, results are from one representative of two 
independent experiments. Each column represents the mean ± SEM of three wells. Statistical significance 
was calculated with One-way ANOVA post-hoc Tukey’s t test (*p < 0.05; **p<0.01; *** p<0.001). bld - 
below detection level. 
 
FIGURE 4: Cytokine production induced by LAM or hLM in vitro is TLR2-mediated.  
(a) Human HEK293 cells transfected with TLR2 were stimulated with 50g/ml of LAM or hLM. Non-
stimulated cells (Medium) or cells stimulated with 50 ng/ml Pam3CSK4 served as a controls. After 24 
hours at 37
o
C, supernatants were harvested and analysed for IL-8 using ELISA. (b) Fold induction of 
mRNA expression of IL-12p40, IL-12p35, IL-23p19, IL-6, TNF-α and IL-10 was evaluated by real time-
PCR after 6 hours of LAM or hLM stimulation (10µg/mL) of 1x10
6
 BL/6 or TLR2
-/- 
DC, relatively to 
non-stimulated cells. Results are from one representative of two independent experiments. (c) Production 
of IL-6, TNF-α and IL-10 was evaluated by ELISA after 24 hours of LAM, hLM (both at 10µg/mL) or 
LPS stimulation (25ng/mL) of 1x10
6
 BL/6 and TLR2
-/-
 DC. Unstimulated DC (Medium) were included as 
a control. In all cases, results are from one representative of two independent experiments. Each column 
represents the mean ± SEM of three wells. Statistical significance was calculated with One-way ANOVA 
post-hoc Tukey’s t test (*p < 0.05; **p<0.01; ***p<0.001). bld - below detection level. 
 
FIGURE 5: In vivo cytokine production induced in the peritoneal cavity by LAM and hLM 
injections requires recognition by other PRRs than TLR2.  
LAM and hLM (50μg in 100μL) were intra-peritoneally injected into BL/6 WT or TLR2-/- mice and 
PECs collected 0, 4 and 8 hours post-injection. (a) mRNA was extracted from 5x10
5
 PECs/animals and 
IL-6, TNF-α, IL-10 and CXCL2 mRNA expression was evaluated by RT-PCR. The data points represent 
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the mean ± SEM of 5 animals. (b) The number of neutrophils was calculated by taking into account the 
percentage of neutrophils determined by flow cytometry (Ly6G
+
GR1
+
CD11b
+
) and the total number of 
cells collected. The data points represent the Mean ± SEM of 5 animals. Results are from one 
representative of two independent experiments. Statistical significance was calculated with two-way 
ANOVA test with 95% confidence (*p < 0.05). 
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
  
